KRAS mutational status affects oxaliplatin-based...

British Journal of Cancer 2013 / 01 Vol. 108; Iss. 1

KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients

Basso, M, Strippoli, A, Orlandi, A, Martini, M, Calegari, M A, Schinzari, G, Di Salvatore, M, Cenci, T, Cassano, A, Larocca, L M, Barone, C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
108
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2012.526
Date:
January, 2013
File:
PDF, 217 KB
english, 2013
Conversion to is in progress
Conversion to is failed